{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:33:26Z","timestamp":1790721206290,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"Deutsches Zentrum f\u00fcr Herz-Kreislaufforschung","doi-asserted-by":"publisher","award":["81X2710128"],"award-info":[{"award-number":["81X2710128"]}],"id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018681","name":"ADUMED-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.yjmcc.2018.05.012","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T02:06:39Z","timestamp":1526868399000},"page":"53-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats"],"prefix":"10.1016","volume":"120","author":[{"given":"Justus","family":"Stenzig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Schneeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"L\u00f6ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Rong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Ling","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit","family":"H\u00f6ppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Geertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N.","family":"Hirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Reichenspurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.-Y.","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Eschenhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2018.05.012_bb0005","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCHEARTFAILURE.108.839761","article-title":"Small animal models of heart failure: development of novel therapies, past and present","volume":"2","author":"Patten","year":"2009","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0010","series-title":"WHO Fact Sheet No. 317 Cardiovascular Diseases (CVDs)","author":"WHO","year":"2013"},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0015","series-title":"Atlanta","author":"Heart Failure Fact Sheet","year":"2015"},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0020","series-title":"Gesundheit - Todesursachen in Deutschland","author":"Germany FSIo","year":"2015"},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.0000197782.21444.8f","article-title":"Control of cardiac growth by histone acetylation\/deacetylation","volume":"98","author":"Backs","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00395-013-0361-1","article-title":"Epigenetics: a new mechanism of regulation of heart failure?","volume":"108","author":"Papait","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12418","article-title":"DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy","volume":"7","author":"Greco","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrcardio.2015.71","article-title":"Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure","volume":"12","author":"Greco","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature12433","article-title":"Charting a dynamic DNA methylation landscape of the human genome","volume":"500","author":"Ziller","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0050","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1161\/CIRCULATIONAHA.111.040071","article-title":"Distinct epigenomic features in end-stage failing human hearts","volume":"124","author":"Movassagh","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.yjmcc.2018.05.012_bb0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/emmm.201201553","article-title":"Alterations in cardiac DNA methylation in human dilated cardiomyopathy","volume":"5","author":"Haas","year":"2013","journal-title":"EMBO Mol Med."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0060","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1038\/ncomms6288","article-title":"Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease","volume":"5","author":"Gilsbach","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0065","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.yjmcc.2015.03.007","article-title":"Experimental heart failure modelled by the cardiomyocyte-specific loss of an epigenome modifier, DNMT3B","volume":"82","author":"Vujic","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131019","article-title":"Cardiac myocyte De novo DNA methyltransferases 3a\/3b are dispensable for cardiac function and remodeling after chronic pressure overload in mice","volume":"10","author":"Nuhrenberg","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0075","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41467-017-01724-9","article-title":"DNA methylation signatures follow preformed chromatin compartments in cardiac myocytes","volume":"8","author":"Nothjunge","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0080","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nrg2651","article-title":"Rethinking how DNA methylation patterns are maintained","volume":"10","author":"Jones","year":"2009","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.yjmcc.2018.05.012_bb0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/cvr\/cvt264","article-title":"Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats","volume":"101","author":"Xiao","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.05.012_bb0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1074248415591698","article-title":"Epigenetic therapy for the treatment of hypertension-induced cardiac hypertrophy and fibrosis","volume":"21","author":"Watson","year":"2015","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1172\/JCI69739","article-title":"Clinical development of demethylating agents in hematology","volume":"124","author":"Navada","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0100","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm.2828","article-title":"Epigenetic mechanisms in neurological disease","volume":"18","author":"Jakovcevski","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.23607","article-title":"Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine","volume":"123","author":"Stresemann","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0110","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1182\/blood-2011-11-382226","article-title":"RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia","volume":"119","author":"Aimiuwu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00395-015-0528-z","article-title":"DNA methylation in an engineered heart tissue model of cardiac hypertrophy: common signatures and effects of DNA methylation inhibitors","volume":"111","author":"Stenzig","year":"2016","journal-title":"Basic Res. Cardiol."},{"issue":"5","key":"10.1016\/j.yjmcc.2018.05.012_bb0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/bcpt.12514","article-title":"Pharmacokinetics of the experimental non-nucleosidic DNA methyl transferase inhibitor N-phthalyl-l-tryptophan (RG 108) in rats","volume":"18","author":"Schneeberger","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-2003-42264","article-title":"Experimental model for heart failure in rats\u2014induction and diagnosis","volume":"51","author":"Zaha","year":"2003","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-2003-42264","article-title":"Experimental model for heart failure in rats\u2014induction and diagnosis","volume":"51","author":"Zaha","year":"2003","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0135","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1109\/CIC.2005.1588172","article-title":"Time resolved three-dimensional segmentation of the left ventricle","volume":"32","author":"Heiberg","year":"2005","journal-title":"Proc. IEEE Comput. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0145","first-page":"1105","article-title":"TopHat: discovering splice junctions with RNA-Seq","volume":"25","author":"Trapnell","year":"2009","journal-title":"Bioinformatics (Oxford, England)."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0150","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0155","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.yjmcc.2007.05.003","article-title":"Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure","volume":"43","author":"El-Armouche","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0165","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nprot.2010.190","article-title":"Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling","volume":"6","author":"Gu","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0170","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1158\/0008-5472.CAN-04-2957","article-title":"Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases","volume":"65","author":"Brueckner","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0175","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1021\/jm401419p","article-title":"Synthesis and evaluation of analogues of N-phthaloyl-l-tryptophan (RG108) as inhibitors of DNA methyltransferase 1","volume":"57","author":"Asgatay","year":"2014","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.yjmcc.2018.05.012_bb0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13238-013-0016-x","article-title":"Global DNA methylation and transcriptional analyses of human ESC-derived cardiomyocytes","volume":"5","author":"Gu","year":"2013","journal-title":"Protein Cell."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0185","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yexcr.2010.08.017","article-title":"Identification of cardiomyocyte nuclei and assessment of ploidy for the analysis of cell turnover","volume":"317","author":"Bergmann","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0190","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1073\/pnas.1318948111","article-title":"Defining functional DNA elements in the human genome","volume":"111","author":"Kellis","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0195","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/01.RES.0000077012.11088.BC","article-title":"Phenotyping hypertrophy: eschew obfuscation","volume":"92","author":"Dorn","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0200","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00395-012-0307-z","article-title":"Increased afterload induces pathological cardiac hypertrophy: a new in vitro model","volume":"107","author":"Hirt","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0205","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/hmg\/ddt614","article-title":"Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype","volume":"23","author":"Watson","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0210","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1074248415591698","article-title":"Epigenetic therapy for the treatment of hypertension-induced cardiac hypertrophy and fibrosis","volume":"21","author":"Watson","year":"2016","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0215","first-page":"3093","article-title":"Induction of apoptosis by 5-azacytidine: drug concentration-dependent differences in cell cycle specificity","volume":"55","author":"Murakami","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrg3354","article-title":"DNA methylation: roles in mammalian development","volume":"14","author":"Smith","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0225","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature06544","article-title":"Cyclical DNA methylation of a transcriptionally active promoter","volume":"452","author":"Metivier","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166575","article-title":"5'-Hydroxymethylcytosine precedes loss of CpG methylation in enhancers and genes undergoing activation in cardiomyocyte maturation","volume":"11","author":"Kranzhofer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0235","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrg.2017.33","article-title":"TET-mediated active DNA demethylation: mechanism, function and beyond","volume":"18","author":"Wu","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0240","doi-asserted-by":"crossref","first-page":"H1363","DOI":"10.1152\/ajpheart.00395.2013","article-title":"Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis","volume":"305","author":"Kong","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2015.12.031","article-title":"Origins of cardiac fibroblasts","volume":"91","author":"Moore-Morris","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0250","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/cvr\/cvv015","article-title":"Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis","volume":"105","author":"Xu","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0255","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.addr.2015.05.010","article-title":"Human engineered heart tissue as a model system for drug testing","volume":"96","author":"Eder","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0260","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1093\/nar\/gkw159","article-title":"Repurposing the CRISPR-Cas9 system for targeted DNA methylation","volume":"44","author":"Vojta","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.09.006","article-title":"Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing","volume":"167","author":"Amabile","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2018.05.012_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.08.056","article-title":"Editing DNA methylation in the mammalian genome","volume":"167","author":"Liu","year":"2016","journal-title":"Cell"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818301731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282818301731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T05:59:14Z","timestamp":1762667954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282818301731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":54,"alternative-id":["S0022282818301731"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.05.012","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2018.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}